Figure 7

The incidences of adverse events of the different PEX168 doses compared to metformin. Forest plots of network meta-analysis are shown for the pooled risk ratios of the different PEX168 doses compared to metformin for any adverse events (AEs), nausea, diarrhea, and discontinuation of the study due to AEs.